Shrier Wealth Management’s Novartis NVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$3.39M Sell
23,749
-135
-0.6% -$20.5K 1.14% 25
2026
Q2
$3.74M Buy
23,884
+183
+0.8% +$27.4K 1.26% 23
2026
Q1
$3.62M Sell
23,701
-376
-2% -$57.6K 1.32% 19
2025
Q4
$3.32M Buy
+24,077
New +$3.15M 1.31% 20

Other funds holding NVS

Shrier Wealth Management's NVS Position: Q3 2026 in Review

Shrier Wealth Management reduced its Novartis (NVS) stake by 0.57% in Q3 2026, selling an estimated $20.5K and leaving 23,749 shares worth $3.39M. The position accounts for 1.14% of the portfolio, ranked #25.

Shrier Wealth Management first reported a position in NVS in Q4 2025 and has held it in 4 quarters since. The position peaked at $3.74M in Q2 2026. 1,560 funds tracked by Wall St. Rank hold NVS as of Q3 2026.

  • Shrier Wealth Management held 23,749 shares of Novartis worth $3.39M as of Q3 2026.
  • Shrier Wealth Management sold 135 Novartis shares in Q3 2026, an estimated $20.5K.
  • Novartis made up 1.14% of Shrier Wealth Management's portfolio in Q3 2026, its #25 holding.
  • Shrier Wealth Management first reported a position in Novartis in Q4 2025 and has held it in 4 quarters since.
  • Shrier Wealth Management's Novartis position peaked at $3.74M in Q2 2026.
  • 1,560 funds tracked by Wall St. Rank held Novartis as of Q3 2026.

Based on Shrier Wealth Management's 13F filing for Q3 2026, filed 20 Oct 2026.